If you need more lookups,
subscriptions start at $34 USD/month.
Kate Tighe Location
New York, NY, US
Kate Tighe Work
2026 -now VP, Patient Advocacy @
2023 -now Chair, Board of Directors @
2022 -2026 VP, Head, US Public Affairs and Patient Advocacy - Immunology @
2019 -2022 VP, Head of US Public Affairs and Patient Advocacy - Rare Diseases @
2017 -2019 Associate Director, Global Patient Advocacy- Rare Diseases @
2016 -2016 Associate Director, Site Engagement and Patient Recruitment (Global) @
2015 -2016 Manager, Patient Advocacy @
2008 -2015 Area Director @
2006 -2008 Development and Philanthropic Services Associate (Boston Bar Foundation) @
2006 -2006 Legislative Aide @
Kate Tighe Education
Simmons College
Bachelor of Arts (International Relations; Economics)
2001-2005
Kate Tighe Skills
Nonprofits
Event Planning
Volunteer Management
Fundraisers
Sponsorship
Event Management
Management
Public Speaking
Community Outreach
Public Relations
Media Relations
Non-profits
Social Media
Strategic Communications
Fundraising
Policy Analysis
Donor Recognition
Donor Management
Donor Development
Donor Engagement
New Business Development
Business Strategy
Business Analysis
Business Planning
Charity Governance
Charity Marketing
Cause Marketing
Logistics Management
Budget Setting
Budget Monitoring
Financial Goals
Patient Advocacy
Marketing
Global Regulatory Compliance
Market Research
Patient Advisory Boards
Non Profits
Leadership
Strategic Planning
Kate Tighe Summary
Kate Tighe, based in New York, NY, US, is currently a VP, Patient Advocacy at BioMarin Pharmaceutical Inc.. Kate Tighe brings experience from previous roles at Courageous Parents Network and Sanofi. Kate Tighe holds a 2001 - 2005 Bachelor of Arts in International Relations; Economics @ Simmons College. With a robust skill set that includes Nonprofits, Event Planning, Volunteer Management, Fundraisers, Sponsorship and more. Kate Tighe has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kate Tighe?
Find contact details for 700 million professionals.